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Abstract 
Flow cytometry is one of the core technologies for a single cell analysis and sorting based on fluorescent markers and 
functional probes. Nevertheless, popular adoption and proliferation of this technology is still limited by the high cost, 
need for dedicated personnel, lack of miniaturization and requirement for considerable sample volumes. In this work 
we demonstrate that advanced multiparameter assays to track the caspase-dependent cell death can be rapidly 
performed using innovative microfluidic flow cytometry (μFCM). This enabling technology features a user-friendly 
chip-based system integrated with the dedicated off-chip electronic interface. It can perform multivariate analysis 
using sampling volumes as small as 10 microlitres. We for the first time present evidence that microfluidic flow 
cytometry can be used to resolve the DNA content and track the pharmacologically induced activation of caspases 
and dissipation of mitochondrial inner membrane potential (m) in relation to the cell cycle in living human tumor 
cells. 
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1. Introduction 
Single-cell analysis of programmed cell death is widely used to assess the efficacy of anti-cancer 
chemotherapeutic agents, as well as to study the heterogeneity of tumour cell responses to selected stress 
signals [1,2]. In this context flow cytometry (FCM) is one of the core technologies for the single cell 
analysis and sorting based on fluorescent markers/probes [3,4]. Nevertheless, wide adoption of FCM is 
still limited by inherent high costs, the need for dedicated personnel, the lack of 
 
* Corresponding author. Tel.: +64-9-373-7599 Ext 82379; fax: +64-9-373-7422. 
E-mail address: d.wlodkowic@auckland.ac.nz or donald.wlodkowic@rmit.edu.au . 
Available online at www.sciencedirect.com
© 2012 The Authors. Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Symposium Cracoviense 
Sp. z.o.o. Open access under CC BY-NC-ND license.
Open access under CC BY-NC-ND license.
89 Jin Akagi et al. /  Procedia Engineering  47 ( 2012 )  88 – 91 
miniaturization/portability, and requirement of high sample volumes [4,5]. Moreover, the high-level of 
automation and user-friendliness has still not been achieved. In this context the development of 
microfluidic, Lab-on-a-Chip (LOC) technologies is one of the most innovative and cost-effective 
approaches towards the advancement of FCM [4,5]. Here we describe development of miniaturized and 
user friendly microfluidic flow cytometer (μFCM) that can perform multivariate analysis of cells and 
particles using sampling volumes as small as 10 microlitres. We also demonstrate that advanced 
supravital assays to track the caspase-dependent tumour cell death can be rapidly performed using μFCM. 
2. Materials and Methods 
Human leukemic U937 and THP1 cell lines were purchased from American Type Culture Collection 
(ATCC, USA) and cultured in an Advanced RPMI 1640 culture medium supplemented with 5% FBS as 
described previously [2.4]. Cells were always in asynchronous and exponential phase of growth. 
Computational fluid dynamics (CFD) was utilized to comprehend the performance of the 
microcytometric system. The 3D chip model was designed using SolidWorks 2011 (SolidWorks Corp, 
USA) package. The geometry was then exported to Gambit 2.3 software (Fluent, Lebanon, NH, USA) to 
create a mash file and finite-volume based Fluent 6.3 software (Fluent) was used to solve the associated 
differential equations.  
The microfluidic, disposable chips were fabricated in optically transparent thermoplastic poly(methyl 
methacrylate) (PMMA) using proprietary injection moulding and UV bonding technology (On-Chip 
Biotechnologies Co Ltd, Japan). The off-chip hardware analyser was equipped with two solid-state lasers 
(blue; 473 nm and red; 640 nm) and four photomultiplier tube-based (PMT) detection channels with 
band-pass filters: FL1 (530 ± 21 nm), FL2 (585 ± 20 nm), FL3 (692 ± 20 nm), and FL4 (775 ± 23 nm 
nm). The use of spectrally dissimilar probes eliminated the need for deconvolution of the fluorescent 
signals. A typical run used a sample with 2.5-5x103 cells.  
Analysis of data was performed using Fishman R software (On-chip Biotechnologies Co Ltd). For 
data presentation native data files were converted to FCS 3.0 standard using Fishman-R data converter 
and analysed using a FCS Express 4 RUO Flow Cytometry (De Novo Software, USA) software suite. 
3. Results 
The planar PMMA microcytometry chip was designed to provide a 2D hydrodynamic cell focusing of 
cells into single file (Fig 1a & b). The chip featured three integrated modules: (i) the input port with cell 
sample (200 μl) and sheath fluid (2 ml) reservoirs, (ii) a cell focusing and analysis manifold with a 
channel width 75 μm and depth 50 μm; and (iii) the output port with cell sample (200 μl) and sheath fluid 
(2 ml) collection chambers (Fig 1a). The CFD simulations predicted the parabolic velocity profiles across 
the detection channel with maximum and average values of 1.557 and 0.68 m/s, respectively. Despite of 
such high velocities the Reynolds number based on the hydraulic diameter of the detection channel was 
41.7 corresponding to the laminar characteristics of the flow. The sample flow in the microfluidic chip 
was generated by air-over-liquid system with positive pressure generated using the microcontroller-
driven, embedded syringe pump and adjustable between 1 to 20 μl/min. The indirect actuation using an 
interface cradle ensured that the off-chip interface device remained free from any liquid/sample contact 
and thus potential cross-contamination (Fig 2a & b). The electronic hardware interface enabled up to 
four-color detection using a combination of spatially separated solid-state 473 (10 mW) and 640 nm (20 
mW) lasers and x-y axis stage for laser alignment adjustments (Fig 2c). Conventional photomultiplier 
tubes (PMTs) were used for fluorescent signal collection in area, height and width parameters for all four 
fluorescent channels (Fig 2b & c). The estimated sensitivity of the system was within specifications of 
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conventional flow cytometers (FITC < 600 MESF, PE < 200 MESF; Molecules of Equivalent Soluble 
Fluorochrome). Additionally the system included true Forward Site Scatter (a representative of cell size) 
and Side Site Scatter (a representative of cell complexity/granularity) detection, using a photodiode and 
SLER (Side scattered Light detection using Edge Reflection of chip) technology, respectively (Fig 2c) 
 
 
 
 
 
 
 
 
 
 
(a)          (b) 
Fig. 1. (a) Disposable microfluidic PMMA chip designed to provide a stable 2D hydrodynamic cell focusing into a single cell file; 
(b) Microphotograph showing the hydrodynamic focusing inside the chip-based cytometer. The middle channel was injected with 
tetramethyl rhodamine methyl (TMRM) ester probe and chip was pressurized at approximately 30 kPa. 
 
We next demonstrated the feasibility of using a microfluidic flow cytometric system for 
multiparameter analysis of apoptosis and pharmacological dose-response profiling of anti-cancer agents 
on ultra low volume samples of human hematopoietic cancer cell lines.  Despite the simple chip design 
with only 2D flow focusing we found that this device was suitable to resolve the DNA content (Fig 3a) 
and simultaneously track the pharmacologically-induced activation of caspases and dissipation of 
mitochondrial inner membrane potential (m) in living cells (Fig 3a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a)         (b)               (c) 
Fig. 2. (a) Microfluidic chip placed inside the adaptor/interfacing cradle for air-over-liquid pressurization of the device; (b) x-y stage 
used for laser alignment adjustments integrated with positive pressure output; (c) The optical path of microflow cytometer. Side 
scatter detection is performed using innovative SLER technology (Side scattered Light detection using Edge Reflection). 
 
We also set to explore whether microfluidic cytometry system can be integrated with on-chip cell culture 
and on-demand, time-lapse cytometric analysis to provide economical solutions for drug discovery and a 
superior degree of real-time bioassay automation. For this purpose we developed a two-colour real-time 
bioassay utilizing both inert plasma permeability marker DRAQ7 and m sensitive probe TMRM to 
obtain unique capability to perform real-time monitoring of mitochondrial membrane inner membrane 
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potential without any additional staining and washing steps. This provided us also with an opportunity to 
investigate kinetic action of small-molecule Bcl-2 inhibitors such as TW37. Figure 3b depicts an on-
demand, near-real-time microflow cytometric assay where cells were continuously grown in the presence 
of both probes on a chip-based device and then sampled (10-20 μl volume samples) every 10 minutes to 
provide the kinetic profile of drug action. Most notably we were able to demonstrate that even though the 
dissipation of m occurred within 10-15 min following challenge with BH3 mimetic TW37 the gradual 
loss of plasma integrity ensued only after 8 hours of stimulation while nearly 74% of cells can sill be 
considered TMRMlow/DRAQ7neg after 24 hours. This indicated that THP1 cells were able to compensate 
for the m loss for a considerable amount of time before committing to cell demise. 
 
 
 
 
 
 
 
 
 
       (a)                          (b) 
Fig. 3. (a) Multiparameter analysis of caspase-dependent apoptosis in relation to the cell cycle profile (DNA content) using 
microfluidic flow cytometer with hydrodynamic 2D cell focusing. Human monocytic leukaemia THP1 cells were stimulated with a 
kinase inhibitor Staurosporine (0.01 μM) in the presence of pan-caspase marker PhiPhiLux. After 24 hours of culture cells were live 
stained with DRAQ5 for 20 min at RT and immediately analysed; (b) Kinetic analysis of small-molecule Bcl-2 inhibitor TW37 
using real-time DRAQ7 (3 μM) / TMRM (200 nM) assay and time-lapse sampling using microfluidic chip-based cytometer. 
4. Conclusions 
In this work we demonstrate how the combined use of inert, real-time fluorescent assays and state-of-
the-art microfluidic flow cytometry platforms can provide cost-effective solution for accelerated analysis 
of investigational anti-cancer agents in hematopoietic cancer cells. The data can be readily acquired on 
living cells samples in the complete medium without any washing or centrifugation steps compromising 
the assay’s sensitivity. The microfluidic chip can also be used to sample a greatly reduced number of cells 
when compared with conventional flow cytometer. This ability is of particular importance in studying the 
outcome of patient derived cancer cells, when exposed to therapeutic drugs, as these cells are often rare 
and difficult to collect and purify.  
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